Regeneron Pharmaceuticals reported $14.29 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 13.04 11.83 Oct/29
FY2026Q2 Jun/2026 14.29 10.85 12.89 Jul/30
FY2026Q1 Mar/2026 9.47 9.13 8.22 Apr/29
FY2025Q4 Dec/2025 11.44 10.61 12.07 Jan/30
FY2025Q3 Sep/2025 11.83 9.67 12.46 Oct/28




Eps Change Date
AbbVie USD 3.65 1 Jun/2026
Agenus USD 1.02 1.32 Mar/2026
Agios Pharmaceuticals USD -1.69 0 Jun/2026
Alnylam Pharmaceuticals USD 1.84 0.15 Jun/2026
Amgen USD 5.15 0.14 Mar/2026
Astellas Pharma JPY 24.29 31.75 Mar/2026
AstraZeneca USD 2.63 0.05 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
Incyte USD 3.09 1.28 Jun/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Kyowa Hakko Kirin JPY 35.49 12.5 Jun/2026
Merck USD -1.28 3.32 Mar/2026
Moderna USD -1.97 1.43 Jun/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Novartis USD 2.41 0.42 Jun/2026
Novartis USD 1.99 0.45 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 2.17 2.84 Mar/2026
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Teva Pharmaceutical Industries USD 0.06 1.51 Jun/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
United Therapeutics USD 5.82 1.88 Mar/2026
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026